Molecular defects identified in a cohort of 140 patients with HIGM
. | . | Number of patients . | . | . | |
|---|---|---|---|---|---|
| Gene . | Percentage* . | Male . | Female . | Number of families . | |
| CD40L | 70.0 | 98 | 0 | 77 | |
| AID | 2.9 | 3 | 1 | 4 | |
| CD40 | 0 | 0 | 0 | 0 | |
| NEMO | 0.7 | 1 | 0 | 1 | |
| ICOS | 0 | 0 | 0 | 0 | |
| ICOSL | 0 | 0 | 0 | 0 | |
| UNG2 | 0.7 | 1 | 0 | 1 | |
| Btk | 2.1 | 3 | 0 | 2 | |
| SAP | 0 | 0 | 0 | 0 | |
| Unknown | 23.6 | 24 | 9 | 30 | |
| Total | 100 | 130 | 10 | 115 | |
. | . | Number of patients . | . | . | |
|---|---|---|---|---|---|
| Gene . | Percentage* . | Male . | Female . | Number of families . | |
| CD40L | 70.0 | 98 | 0 | 77 | |
| AID | 2.9 | 3 | 1 | 4 | |
| CD40 | 0 | 0 | 0 | 0 | |
| NEMO | 0.7 | 1 | 0 | 1 | |
| ICOS | 0 | 0 | 0 | 0 | |
| ICOSL | 0 | 0 | 0 | 0 | |
| UNG2 | 0.7 | 1 | 0 | 1 | |
| Btk | 2.1 | 3 | 0 | 2 | |
| SAP | 0 | 0 | 0 | 0 | |
| Unknown | 23.6 | 24 | 9 | 30 | |
| Total | 100 | 130 | 10 | 115 | |
Percentage of all patients.